By Nimesh Vora, Bharath Rajeswaran and Jaspreet Kalra MUMBAI, July 1 (Reuters) - Global fund managers are reassessing their ...
Researchers from The University of Texas MD Anderson Cancer Center demonstrated that an artificial intelligence (AI)-based ...
Taysha Gene Therapies (TSHA) remains a Buy on strong TSHA-102 Rett data, FDA-aligned pivotal path, and cash to 2028—read the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results